DYNAVAX TECHNOLOGIES CORP Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-07-11: Reporting owner Janssen Robert; Form 3; Security Restricted Stock Unit; Transaction Holding.
- 2013-07-09: Reporting owner Janssen Robert; Form 4; Security Restricted Stock Unit; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-07-11 holding as of filing | Janssen Robert Officer (Chief Medical Officer and VP) | 3 | Restricted Stock Unit Derivative · Direct | Holding | $4.22 exercise price | 2013-07-11 | ||
| 2013-07-09 | Janssen Robert Officer (Chief Medical Officer and VP) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $1.16 exercise price | 2013-07-11 |